Mapping of health technology assessment in China:a comparative study between 2016 and 2021  

作　　者：Shimeng Liu Yu Xia Yi Yang Jian Ming Hui Sun Yan Wei Yingyao Chen 

机构地区：[1]School of Public Health,Fudan University,Shanghai 200032,China [2]National Health Commission Key Laboratory of Health Technology Assessment(Fudan University),Shanghai,200032,China [3]Shanghai Health Development Research Center,Shanghai 201199,China

出　　处：《Global Health Research and Policy》2024年第1期578-586,共9页全球健康研究与政策(英文)

基　　金：supported by China Medical Board(CMB)under Grant 19-318,A Demonstration Program on Health Technology Assessment in China.

摘　　要：Background Health Technology Assessment(HTA)in China has recently expanded from purely academic research to include policy or decision-oriented practice,especially after HTA evidence was used to update the National Reim-bursement Drug List for the first time in 2017.This study aims to identify the progress and challenges of HTA develop-ment from 2016 to 2021 and inform policies and decisions to promote further HTA development in China.Methods We conducted a cross-sectional web-based survey with policy makers,researchers and industry-providers in China in 2016 and 2021 respectively.The‘Mapping of HTA Instrument’,was utilized to assess the HTA development across eight domains:Institutionalization,Identification,Priority setting,Assessment,Appraisal,Reporting,Dissemina-tion of findings and conclusions,and Implementation in policy and practice.To reduce the influence of confound-ers and compare the mapping outcomes between the 2016 and 2021 groups,we conducted 1:1 Propensity Score Matching(PSM).Univariate analysis was conducted to compare the differences between the two groups.The overall results were further compared with those of a mapping study that included ten countries.Results In total,212 and 255 respondents completed the survey in 2016 and 2021,respectively.The total score of the HTA development level in China in 2021 was higher than that in 2016 before PSM(89.38 versus 83.96).Follow-ing PSM,183 respondents from the 2016 and 2021 groups were matched.Overall,the mean scores for most indicators in the Institutionalization domain and Dissemination domain in 2021 were higher than those in 2016(P<0.05).The Appraisal domain in 2021 was more explicit,transparent and replicable than that in 2016(t=-3.279,P<0.05).How-ever,the mean scores of most indicators in the Assessment domain were higher in 2016 than those in 2021(P<0.05).Conclusions Our study suggest that the level of HTA development in China progressed significantly from 2016 to 2021.However,before engaging in HTA activities,further efforts are required to

关 键 词：Health technology assessment MAPPING Development level Propensity score matching China 

分 类 号：F42[经济管理—产业经济]